Amount raised
$87M
Round
Series C
Date raised
November 18, 2026
Founded
—
CompanyVitriVax
IndustryBiotechnology
InvestorsF-Prime Capital, New Enterprise Associates, RA Capital Management, Sanofi Ventures
Websitevitrivaxbio.com
Leadership
- Romulo ColindresPresident/CEO
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About VitriVax
a vaccine development and formulation technology company
- How much did VitriVax raise?
- VitriVax raised $87M in a Series C round on November 18, 2026. Investors include F-Prime Capital, New Enterprise Associates, RA Capital Management, Sanofi Ventures.
- Who runs VitriVax?
- Romulo Colindres (President/CEO) is listed as VitriVax's officer.